Addex Therapeutics Ltd American Depositary Shares

Go to Addex Therapeutics Ltd American Depositary Shares Website

$8.13

0.00 (0.00%)
Live
Previous Close

$8.13

Day Range

$0 - $0

Previous Day Range

$8.13 - $8.19

Market Cap

$8.7 million USD

Day Vol.

0

Previous Day Vol.

1728

Currency

USD

Primary Exchange

Nasdaq

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's ge...


Community
  • 0 posts discussing
0

Watchers

1

Visitors


Recent News

Addex Therapeutics invested CHF 2 million in Stalicla, a clinical-stage company focusing on precision medicine for neurodevelopmental disorders. The investment supports Stalicla's autism drug candidates and clinical trials, with Addex CEO Tim Dyer joining Stalicla's Board of Directors.

Related tickers: ADXN.

Read Full Article

Stalicla, a Swiss clinical-stage biotech company, secured CHF 2 million in financing from Addex Therapeutics to advance its precision medicine neurodevelopmental disorder programs, including preparing for Series C financing and progressing clinical trials for autism and substance use disorder treatments.

Related tickers: ADXN.

Read Full Article
Trending Tickers

Please sign in to view